Source: WeedStreet420
  • Nabis Holdings (NAB) has closed the first tranche of its non-brokered private placement for aggregate gross proceeds of $380,000
  • The company issued 1,900,000 common shares priced at $0.20 per share
  • Nabis Holdings invests in assets across multiple industries including the cannabis sector
  • Nabis Holdings Inc. (NAB) opened trading at C$0.27 per share

Nabis Holdings (NAB) has closed the first tranche of its non-brokered private placement for aggregate gross proceeds of $380,000.

The company issued 1,900,000 common shares priced at $0.20 per share.

The net proceeds will be used for working capital and general corporate purposes.

The securities issued will be subject to a four-month hold period from the date of closing.

The closing of the offering is subject to the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange.

Nabis Holdings is a Canadian investment issuer that invests in assets across multiple industries, including real property and the U.S. and international cannabis sector.

Nabis Holdings Inc. (NAB) opened trading at C$0.27 per share.

More From The Market Online
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Quarterly report season heats up

Vertically-integrated producer of premium-grade cannabis products, Cannara Biotech Inc. reported gross cannabis revenues before excise taxes...
Cannabis Report across cannabis plants

StockTalk | Cannabis Report: Shake-ups

MediPharm Labs announced that chief executive officer, David Pidduck will step down from his role, effective January...

Buzz on the Bullboards: As Arctic tensions flare, investors eye three news‑making stocks

Global markets opened the week on edge as a fresh rift between Washington and key NATO...

MediPharm Labs announces CEO transition as David Pidduck steps down

MediPharm Labs (TSX:LABS) CEO David Pidduck will step down on January 23, 2026, and will remain on the Board to support the transition.